Program

  Wednesday, September 30, 2020

  Wednesday, October 14, 2020

  Thursday, October 15, 2020

  Friday, October 16, 2020

  Saturday, October 17, 2020



  Wednesday, September 30, 2020

[« back]
• Aluizio Marques Ballroom
Time Activity
6:30pm-8:30pmBCTRIMS Youth League Symposium: Part 1
Case-based discussion
Clinical manifestations: typical vs. atypical
What should I value in neuroimaging?
Everything I should know about CSF in demyelinating disorders
Discussion
8:30pm-10:30pmBCTRIMS Youth League Symposium: Part II
Update: diagnostic criteria
Update: treatment
Discussion

Getting to know the BYL
PROBEN #tbt: national experiences
PROBEN #tbt: international experiences
Fellowships in neuroimmunology in Brazil

  Wednesday, October 14, 2020

[« back]
• Aluizio Marques Ballroom
Time Activity
4:05pm-4:30pmCoffee Break
6:15pm-6:30pmOpening Ceremony
6:30pm-8pmSession: Advances in neuroimaging
Conectivity, cognition and fatigue in MS: How are they related?
Clinical use of 7T MRI in demyelinating diseases
Clinical use of PET-MRI
Myelin imaging: New frontiers of quantitative imaging
Discussion
8pm-9pmPharma symposium
9pm-10pmAluízio Marques Lecture
AQP4-, MOG- and GFAP-related disorders: Clinical approach to the differential diagnosis
Discussion

  Thursday, October 15, 2020

[« back]
• Aluizio Marques Ballroom
Time Activity
07am-08amCase-based Workshop: Multiple sclerosis
Case 1: EMPP Cognitivo (UNICAMP)
Case 2: (PUCRS)
08am-10amScientific session: CTRIMS Session - Part I
Silent progression in RRMS: clinical and cognitive aspects
Genetics of multiple sclerosis: A review
To be defined
To be defined
Preditors of outcome in pediatric NMOSD
Discussion
10am-10:30amCoffee Break
10am-11amPharma symposium
11am-0:30pmScientific session: Translational symposium
Multiple Sclerosis: does translational neuroimmunology exist?
B cell directed immunotherapy of multiple sclerosis: From bench to bedside
In vivo imaging system as a robust and promising tool for neuroimmunology
Discussion
2pm-3:30pmCoffee, fruits and posters discussion session
Panel 1: Immunology and Basic Science
Panel 2: Epidemiology, MS Treatment and MRI
Panel 3: Clinical findings: MS, NMOSD, MONEM, ADEM, CIS
Panel 4: Multidisciplinary Care
4pm-4:30pmCoffee Break
6pm-7:30pmCoffee, fruits and posters discussion session
Panel 3: Clinical findings: MS, NMOSD, MONEM, ADEM, CIS
Panel 4:Multidisciplinary Care
6:30pm-8pmScientific session: Cognition in multiple sclerosis
Toward the implementation of cognitive outcome measures in clinical trials: are we there yet?
Reserve on daily clinical practice: from bench to bedside
Non-pharmacological approaches to MS cognitive dysfunction: evidence from clinical and neuroimaging studies
Platform presentation 1: TBD
Platform presentation 2: TBD
Discussion
8pm-9pmPharma symposium
9pm-10:30pmScientific session: Pediatric onset multiple sclerosis
DMTs in POMS: Experience from clinical practice and clinical trials
POMS: What is different in pediatric patients?
Platform presentation 7: TBD
Platform presentation 8: TBD
Discussion

  Friday, October 16, 2020

[« back]
• Aluizio Marques Ballroom
Time Activity
07am-08amCase-based Workshop: Neuromyelities optica spectrum disorders
Case 1: MONEM (UNESP)
Case 2: NMOSD (CIEM)
08am-09:30amScientific session: Epidemiology of Neuromyelitis Optica Spectrum Disorders
The World epidemiology of NMOSD
NMOSD in Brazil
Causes and risk of death in NMOSD
Discussion
09:30am-10:30amPharma symposium
09:40am-10amCoffee Break
10:30am-0:30pmScientific session: Neuromyelitis optica spectrum disorders – Part I
Pathology and pathophysiology of NMOSD
Biomarkers in diagnosis of demyelinating diseases of the CNS
Immunopathophysiology of MOG-related disorders
Platform presentation 3: TBD
Platform presentation 4: TBD
Discussion
0:45pm-1pmClosing Remarks: Closing remarks and invitation to BCTRIMS 22nd Annual Meeting, 2021
4pm-4:30pmCoffee Break
6:30pm-8pmScientific session: Top 10 of the year: how the best papers impact our practice
Panel
8pm-9pmPharma symposium
9pm-10:30pmScientific session: Neuromyelitis optica spectrum session disorders - Part II
Differential diagnosis of transverse myelitis
Monoclonal Ab in the treatment of NMOSD: Why? When? Which?
Platform presentation 5: TBD
Platform presentation 6: TBD
Discussion

  Saturday, October 17, 2020

[« back]
• Aluizio Marques Ballroom
Time Activity
07am-08amCase-based Workshop: MRI
Case 1: TBD
Case 2: TBD
08am-10amEuropean Charcot Foundation Symposium: PRO Value and Limitations
Methodological aspects: Value and limitations
PROMS Initiative
PRO: the patient’s perspective
Role of PRO in treatment assessment
Discussion
10am-11amPharma symposium
11am-0:45pmHarvard medical school symposium
The role of complement treatments in NMOSD, MOG and MS
To be defined
Best treatment strategies for MOG disease: Acute attacks and immunosuppression
Updates in PML and MS
Misdiagnosis of MS: Common clinical pitfalls
Diagnosis and treatment of patients with spinal cord MS phenotype
Can MS and MOG disease co-exist?


Event Venue

Tivoli Mofarrej São Paulo

Visit a Sao Paulo landmark at the Tivoli Mofarrej São Paulo Hotel. Located in the heart of Jardins, the city’s most desirable district, you’ll be surrounded by fashion boutiques and stunning sights.

  • Five minutes’ walk to the city’s main street, Avenue Paulista
  • soak up incredible Brazilian art at the Museu de Arte de São Paulo (MASP)
  • spend a day shopping along the elegant Rua Oscar Freire
  • see views across Trianon Park from the full-height windows


Alameda Santos, 1437 - Cerqueira César, Sao Paulo - SP, 01419-001 - Brazil



Management


Travel Agency


Support by


Patrocinador Ouro


Patrocinador Prata